Detalhe da pesquisa
1.
Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas.
Acta Pharmacol Sin
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834683
2.
A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel Disease.
Molecules
; 29(8)2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38675622
3.
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo.
Cancer Sci
; 113(2): 709-720, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34855271
4.
Face Manipulation Detection Based on Supervised Multi-Feature Fusion Attention Network.
Sensors (Basel)
; 21(24)2021 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34960275
5.
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.
Mol Cancer
; 19(1): 90, 2020 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32404161
6.
Discovery and biological evaluation of N-(3-(7-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-4-methyl-2-oxo-2H-pyrimido[4,5-d][1,3]oxazin-1(4H)-yl)phenyl)acrylamide as potent Bruton's tyrosine kinase inhibitors.
Acta Pharmacol Sin
; 41(3): 415-422, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31316181
7.
Discovery and Biological evaluation of pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione derivatives as potent Bruton's tyrosine kinase inhibitors.
Bioorg Med Chem
; 27(15): 3390-3395, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31221612
8.
Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.
Mol Cancer
; 22(1): 139, 2023 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37598189
9.
Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.
Mol Cancer
; 20(1): 102, 2021 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34404402
10.
Extracellular derivatives for bone metabolism.
J Adv Res
; 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218580
11.
Organoid bioinks: construction and application.
Biofabrication
; 16(3)2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697093
12.
AI energized hydrogel design, optimization and application in biomedicine.
Mater Today Bio
; 25: 101014, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464497
13.
Diets intervene osteoporosis via gut-bone axis.
Gut Microbes
; 16(1): 2295432, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38174650
14.
MMP13-targeted siRNA-loaded micelles for diagnosis and treatment of posttraumatic osteoarthritis.
Bioact Mater
; 37: 378-392, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689658
15.
Engineering Large-Scale Self-Mineralizing Bone Organoids with Bone Matrix-Inspired Hydroxyapatite Hybrid Bioinks.
Adv Mater
; : e2309875, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642033
16.
Boosting cartilage repair with silk fibroin-DNA hydrogel-based cartilage organoid precursor.
Bioact Mater
; 35: 429-444, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38390528
17.
Synthetic biology-based bacterial extracellular vesicles displaying BMP-2 and CXCR4 to ameliorate osteoporosis.
J Extracell Vesicles
; 13(4): e12429, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38576241
18.
Dual-network DNA-silk fibroin hydrogels with controllable surface rigidity for regulating chondrogenic differentiation.
Mater Horiz
; 11(6): 1465-1483, 2024 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38221872
19.
Bioactive elements manipulate bone regeneration.
Biomater Transl
; 4(4): 248-269, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38282709
20.
Design, Synthesis, and Evaluation of (R)-8-((Tetrahydrofuran-2-yl)methyl)pyrido[2,3-d]pyrimidin-7-ones as Novel Selective ACK1 Inhibitors to Combat Acquired Resistance to the Third-Generation EGFR Inhibitor.
J Med Chem
; 66(10): 6905-6921, 2023 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37134203